Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%
Mahwah, New Jersey, February 12, 2025: Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark’s Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent to […]
